Exenatide treatment causes suppression of serum fasting ghrelin levels in patients with type 2 diabetes mellitus


Guclu M., Kiyici S., Gul Z., ÇAVUN S.

ENDOCRINE CONNECTIONS, vol.7, no.1, pp.193-198, 2018 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 7 Issue: 1
  • Publication Date: 2018
  • Doi Number: 10.1530/ec-17-0242
  • Title of Journal : ENDOCRINE CONNECTIONS
  • Page Numbers: pp.193-198
  • Keywords: exenatide, ghrelin, diabetes, GLYCEMIC CONTROL, INSULIN, WEIGHT, EXENDIN-4, METFORMIN, PEPTIDE, GLP-1, CELL

Abstract

Aim: In the present study, we investigated the long-term effects of exenatide treatment on serum fasting ghrelin levels in patients with type 2 diabetes mellitus.